Prothrombotic effect of prostasomes of metastatic cell and seminal origin

被引:15
作者
Babiker, Adil A.
Hamad, Osama A.
Sanchez, Javier
RonquiSt, Gunnar
Nilsson, Bo
Ekdahl, Kristina Nilsson
机构
[1] Univ Uppsala Hosp, Dept Radiol Oncol & Clin Immunol, Div Clin Immunol, S-75185 Uppsala, Sweden
[2] Univ Hosp, Div Clin Chem, Dept Med Sci, Uppsala, Sweden
[3] Univ Kalmar, Dept Chem & Biomed Sci, Kalmar, Sweden
关键词
tissue factor; coagulation; prostasomes; prostate cancer;
D O I
10.1002/pros.20497
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Prostasomes are secretory granules produced by the glandular epithelial cells of the prostate. Seminal prostasomes contain high amounts of Tissue Factor (TF) but no studies of TF on malignant cell prostasomes have been made. Here we compare the expression, phosphorylation, and function of TF on prostasomes of different origin. METHODS. TIT was detected on prostasomes isolated from seminal fluid and human prostate cancer cell lines (PC-3, DU145, and LNCaP) using FACS and enzyme immunoassay (EIA). Incubation of prostasomes with radioactive ATP under conditions favoring protein kinase A activity led to phosphorylation of TF as detected by immunoprecipitation and SDS-PAGE. The prothrombotic effect of prostasomes was investigated in whole blood and recalcified plasma. Blocking experiments were performed using anti-TF antibodies and corn trypsin inhibitor. RESULTS. TF was expressed on all tested prostasome preparations with lowest values found for seminal ones. Prostasomal TF was the main endogenous substrate for prostasomal protein kinase A. All tested prostasome preparations greatly enhanced the rate of clot formation in a dose-dependent fashion, that is, the clotting capability of prostasomes seemed to be related to the extent of their expression of TF. In addition, the density of the clot varied between different prostasome preparations. When incubated in whole blood, prostasomes were found to associate to WBC thereby inducing them to express and release TF. CONCLUSIONS. These data show that TF is overexpressed and also subjected to phosphorylation by malignant cell prostasomes. This suggests major roles for prostasomes in thrombotic events that occur in some advanced cases of prostate cancer.
引用
收藏
页码:378 / 388
页数:11
相关论文
共 48 条
[1]   Tissue factor expression and angiogenesis in human prostate carcinoma [J].
Abdulkadir, SA ;
Carvalhal, GF ;
Kaleem, Z ;
Kisiel, W ;
Humphrey, PA ;
Catalona, WJ ;
Milbrandt, J .
HUMAN PATHOLOGY, 2000, 31 (04) :443-447
[2]   Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor [J].
Abe, K ;
Shoji, M ;
Chen, J ;
Bierhaus, A ;
Danave, I ;
Micko, C ;
Casper, K ;
Dillehay, DL ;
Nawroth, PP ;
Rickles, FR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8663-8668
[3]   Tissue factor expression and prognosis in patients with metastatic prostate cancer [J].
Akashi, T ;
Furuya, Y ;
Ohta, S ;
Fuse, H .
UROLOGY, 2003, 62 (06) :1078-1082
[4]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[5]  
2-Z
[6]   Interactions between prostasomes and leukocytes [J].
Arienti, G ;
Carlini, E ;
Saccardi, C ;
Palmerini, CA .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1998, 1425 (01) :36-40
[7]   Overexpression of ecto-protein kinases in prostasomes of metastatic cell origin [J].
Babiker, AA ;
Ronquist, G ;
Nilsson, B ;
Ekdahl, KN .
PROSTATE, 2006, 66 (07) :675-686
[8]   Transfer of functional prostasomal CD59 of metastatic prostatic cancer cell origin protects cells against complement attack [J].
Babiker, AA ;
Nilsson, B ;
Ronquist, G ;
Carlsson, L ;
Ekdahl, KN .
PROSTATE, 2005, 62 (02) :105-114
[9]   Transfer of prostasomal CD59 to CD59-deficient red blood cells results in protection against complement-mediated hemolysis [J].
Babiker, AA ;
Ronquist, G ;
Nilsson, UR ;
Nilsson, B .
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2002, 47 (03) :183-192
[10]   Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein [J].
Bogdanov, VY ;
Balasubramanian, V ;
Hathcock, J ;
Vele, O ;
Lieb, M ;
Nemerson, Y .
NATURE MEDICINE, 2003, 9 (04) :458-462